SG3 Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-127,000
Closed -$10.8M 1017
2021
Q4
$10.8M Buy
+127,000
New +$9.92M 0.22% 85
2021
Q3
Sell
-6,100
Closed -$496K 1027
2021
Q2
$496K Hold
6,100
0.02% 656
2021
Q1
$481K Buy
+6,100
New +$478K 0.01% 786
2019
Q2
Sell
-77,500
Closed -$5.31M 408
2019
Q1
$5.31M Buy
+77,500
New +$5.01M 0.53% 47
2018
Q4
Sell
-114,000
Closed -$7.63M 205
2018
Q3
$7.63M Buy
+114,000
New +$7.59M 1.17% 23
2017
Q4
Sell
-5,000
Closed -$364K 136
2017
Q3
$364K Sell
5,000
-76,300
-94% -$5.5M 0.08% 117
2017
Q2
$6.03M Buy
+81,300
New +$6.04M 1.51% 16

Other funds holding CL

SG3 Management's CL Position: Q1 2022 in Review

SG3 Management sold out of Colgate-Palmolive (CL) in Q1 2022, closing a stake of 124,000 shares — an estimated $9.82M sold.

SG3 Management first reported a position in CL in Q2 2017 and held it in 3 quarters. The position peaked at $10.6M in Q4 2021. 1,632 funds tracked by Wall St. Rank hold CL as of Q1 2022.

  • SG3 Management reported no remaining Colgate-Palmolive position as of Q1 2022 after selling out during the quarter.
  • SG3 Management sold 124,000 Colgate-Palmolive shares in Q1 2022, an estimated $9.82M.
  • SG3 Management first reported a position in Colgate-Palmolive in Q2 2017 and held it in 3 quarters.
  • SG3 Management's Colgate-Palmolive position peaked at $10.6M in Q4 2021.
  • 1,632 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2022.

Based on SG3 Management's 13F filing for Q1 2022, filed 16 May 2022.